Close

Teladoc's (TDOC) Updated Q4 Revenue Guidance Tops Consensus

January 9, 2023 8:12 AM EST

Teladoc (NYSE: TDOC) disclosed:

As previously announced, on January 9, 2023, Teladoc Health, Inc. (the “Company” or “we”) will participate in the 41st Annual J.P. Morgan Healthcare Conference. As part of its presentation, the Company intends to announce that it expects total revenue for the year ended December 31, 2022 to be in the range of $2.403 billion to $2.410 billion, including approximately $1 billion from the Company’s BetterHelp mental health product. The Company also continues to expect adjusted EBITDA for the year ended December 31, 2022 to be consistent with the outlook range disclosed in the Company’s third quarter earnings release on October 26, 2022. For the quarter ended December 31, 2022, the Company now expects revenue to be in the range of $633 million to $640 million and continues to expect adjusted EBITDA to be consistent with the outlook range disclosed in the Company’s third quarter earnings release on October 26, 2022. These financial results are preliminary, unaudited and subject to change in connection with the completion of the Company’s financial closing process and the preparation of its audited financial statements for 2022.

(Consensus sees Q4 revenue of $631.1 million)

The information in this Current Report on Form 8-K is furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and such information shall not be deemed to be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News, Guidance, Hot Corp. News, Hot Guidance

Related Entities

JPMorgan, Earnings